Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Severe Keratitis - Pipeline Insight, 2024
... picture of the Severe Keratitis pipeline landscape is provided, which includes the disease overview and Severe Keratitis treatment guidelines. The assessment part of the report embraces in-depth Severe Keratitis commercial assessment and clinical assessment of ... Read More
-
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Cutaneous Lupus Erythematosus – Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor - Pipeline Insight, 2024
... and growth prospects across 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline ... Read More
-
Complicated skin and soft tissue infections (cSSTI) - Pipeline Insight, 2024
... Complicated Skin and Soft Tissue Infections (cSSTI) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and ... Read More
-
Uremic Pruritus and Associated Dry Skin - Pipeline Insight, 2024
... development scenario and growth prospects across the Uremic Pruritus and Associated Dry Skin market. A detailed picture of the Uremic Pruritus and Associated Dry Skin pipeline landscape is provided, which includes the disease overview and ... Read More
-
22q11.2 Deletion Syndrome - Pipeline Insight, 2024
... Syndrome market. A detailed picture of the 22q11.2 Deletion Syndrome pipeline landscape is provided, which includes the disease overview and 22q11.2 Deletion Syndrome treatment guidelines. The assessment part of the report embraces in-depth 22q11.2 Deletion ... Read More
-
Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024
... the Undifferentiated Pleomorphic Sarcoma (UPS) market. A detailed picture of the Undifferentiated Pleomorphic Sarcoma (UPS) pipeline landscape is provided, which includes the disease overview and Undifferentiated Pleomorphic Sarcoma (UPS) treatment guidelines. The assessment part of ... Read More
-
5-HT1B Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Toll-Like Receptor Agonist - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonist - Pipeline Insight, 2024
... 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonist development. The report ... Read More
-
TGF-Beta-1 Inhibitor - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Thymidine Kinase 2 Deficiency (TK2D) - Pipeline Insight, 2024
... growth prospects across the Thymidine Kinase 2 Deficiency (TK2D) market. A detailed picture of the Thymidine Kinase 2 Deficiency (TK2D) pipeline landscape is provided, which includes the disease overview and Thymidine Kinase 2 Deficiency (TK2D) ... Read More
-
Traumatic Brain Injury(TBI) - Pipeline Insight, 2024
... Injury(TBI) market. A detailed picture of the Traumatic Brain Injury(TBI) pipeline landscape is provided, which includes the disease overview and Traumatic Brain Injury(TBI) treatment guidelines. The assessment part of the report embraces in-depth Traumatic Brain ... Read More
-
Postmenopausal Vaginal Atrophy - Pipeline Insight, 2024
... Atrophy market. A detailed picture of the Postmenopausal Vaginal Atrophy pipeline landscape is provided, which includes the disease overview and Postmenopausal Vaginal Atrophy treatment guidelines. The assessment part of the report embraces in-depth Postmenopausal Vaginal ... Read More
-
Cutaneous Lupus Erythematosus- Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Vulvovaginal Candidiasis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2024
... the Relapsing Multiple Sclerosis (RMS) market. A detailed picture of the Relapsing Multiple Sclerosis (RMS) pipeline landscape is provided, which includes the disease overview and Relapsing Multiple Sclerosis (RMS) treatment guidelines. The assessment part of ... Read More
-
Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024
... the Therapy Resistant Psychiatric Disorders market. A detailed picture of the Therapy Resistant Psychiatric Disorders pipeline landscape is provided, which includes the disease overview and Therapy Resistant Psychiatric Disorders treatment guidelines. The assessment part of ... Read More
-
Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2024
... Ubiquitin Specific Proteases (USP) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, ... Read More
-
50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2024
... prospects across 50S Ribosomal Subunit (50S RNA) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental ... Read More
-
5-HT2 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
5-HT2C Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Brain Tumor Therapeutics
... by 2030, growing at a CAGR of 10.5% over the period 2023-2030. MRI, one of the segments analyzed in the report, is expected to record 11.8% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Sepsis- Pipeline Insight, 2024
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Sepsis: Understanding Sepsis: Overview ... Read More
Research Assistance
